Authors’ Reply to Moura et al.: “Safety of Janus Kinase Inhibitors in Older Patients: A Focus on the Thromboembolic Risk”

Detalles Bibliográficos
Autores principales: Rajasimhan, Suraj, Pamuk, Omer, Katz, James D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211588/
https://www.ncbi.nlm.nih.gov/pubmed/33871805
http://dx.doi.org/10.1007/s40266-021-00856-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211588/
https://www.ncbi.nlm.nih.gov/pubmed/33871805
http://dx.doi.org/10.1007/s40266-021-00856-4

Ejemplares similares